Amicus Therapeutics: Q1 Earnings Snapshot
In this article:
PHILADELPHIA (AP) — PHILADELPHIA (AP) — Amicus Therapeutics Inc. (FOLD) on Wednesday reported a loss of $52.9 million in its first quarter.
The Philadelphia-based company said it had a loss of 18 cents per share.
The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 13 cents per share.
The pharmaceutical company posted revenue of $86.3 million in the period, beating Street forecasts. Five analysts surveyed by Zacks expected $82.1 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FOLD at https://www.zacks.com/ap/FOLD
